Kang Hyo Jin, Lee Young-mi, Bae Kwang-Hee, Kim Seung Jun, Chung Sang J
Department of Chemistry, College of Natural Science, Dongguk University, 26 Pil-dong 3-ga, Jung-gu, Seoul 100-715, Republic of Korea.
Acta Crystallogr D Biol Crystallogr. 2013 Aug;69(Pt 8):1514-21. doi: 10.1107/S0907444913010196. Epub 2013 Jul 18.
Caspase-7 is expressed as a proenzyme and is activated by initiator caspases upon the transmission of cell-death signals. Despite extensive structural and biochemical analyses, many questions regarding the mechanism of caspase-7 activation remain unanswered. Caspase-7 is auto-activated during overexpression in Escherichia coli, even in the absence of initiator caspases, indicating that procaspase-7 has intrinsic catalytic activity. When variants of procaspase-7 with altered L2 loops were prepared, a variant with six inserted amino acids showed meaningful catalytic activity which was inhibited by Ac-DEVD-CHO. The kinetic constants of the procaspase-7 variant were determined and its three-dimensional structure was solved with and without bound inhibitor. The homodimeric procaspase-7 bound to the inhibitor revealed an asymmetry. One monomer formed a complete active site bound to the inhibitor in collaboration with the L2 loop from the other monomer, whereas the other monomer had an incomplete active site despite the bound inhibitor. Consequently, the two L2 loops in homodimeric procaspase-7 served as inherent L2 and L2' loops forming one complete active site. These data represent the first three-dimensional structure of a procaspase-7 variant bound to a specific inhibitor, Ac-DEVD-CHO, and provide insight into the folding mechanism during caspase-7 activation and the basal activity level of procaspase-7.
半胱天冬酶 -7 以酶原形式表达,并在细胞死亡信号传递时被起始半胱天冬酶激活。尽管进行了广泛的结构和生化分析,但关于半胱天冬酶 -7 激活机制的许多问题仍未得到解答。半胱天冬酶 -7 在大肠杆菌中过表达时会自动激活,即使在没有起始半胱天冬酶的情况下也是如此,这表明半胱天冬酶原 -7 具有内在催化活性。当制备具有改变的 L2 环的半胱天冬酶原 -7 变体时,一个插入了六个氨基酸的变体显示出有意义的催化活性,该活性被 Ac-DEVD-CHO 抑制。测定了半胱天冬酶原 -7 变体的动力学常数,并在有和没有结合抑制剂的情况下解析了其三维结构。与抑制剂结合的同型二聚体半胱天冬酶原 -7 显示出不对称性。一个单体与来自另一个单体的 L2 环协作形成了一个与抑制剂结合的完整活性位点,而另一个单体尽管结合了抑制剂但仍有一个不完整的活性位点。因此,同型二聚体半胱天冬酶原 -7 中的两个 L2 环作为固有的 L2 和 L2' 环形成了一个完整的活性位点。这些数据代表了与特定抑制剂 Ac-DEVD-CHO 结合的半胱天冬酶原 -7 变体的首个三维结构,并为半胱天冬酶 -7 激活过程中的折叠机制以及半胱天冬酶原 -7 的基础活性水平提供了见解。